Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAXAGLIPTIN vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAXAGLIPTIN vs SITAGLIPTIN: Safety Overview

Metric SAXAGLIPTIN SITAGLIPTIN
Total FAERS Reports 2,468 19,904
Deaths Reported 263 2,412
Death Rate 10.7% 12.1%
Hospitalizations 838 6,668
Average Patient Age 65.5 yrs 67.3 yrs
% Female Patients 47.8% 52.3%
FDA Approval Date Jul 31, 2009 Dec 30, 2025
Manufacturer Glenmark Pharmaceuticals Inc., USA A-S Medication Solutions
Route ORAL ORAL
Marketing Status Discontinued Prescription